Story · Medicine & Biotech

Thaís Santana: Is ARPI Intensification in High-Risk Localized Prostate Cancer a Class Effect?

1 outlet · first reported by OncoDaily on

Thaís Santana, Radiation Oncologist at CEBROM, shared on LinkedIn: “Is ARPI intensification in high-risk localized prostate cancer a class effect? Does the pelvis matter? Four recent trials, read together: DASL-HiCaP: (OncoDaily)

Coverage, in order

  1. OncoDaily obscure
    Thaís Santana: Is ARPI Intensification in High-Risk Localized Prostate Cancer a Class Effect?

    Thaís Santana, Radiation Oncologist at CEBROM, shared on LinkedIn: “Is ARPI intensification in high-risk localized prostate cancer a class effect? Does the pelvis matter? Four recent trials, read together: DASL-HiCaP:

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.